India – Cyril Amarchand Mangaldas Advised Akums Drugs And Pharmaceuticals Limited (The “Company”) On The Initial Public Offering Of 27,368,151 Equity Shares Aggregating To INR 18,567.37 Million.

India – Analysis of Delhi High Court’s Judgment On Permanent Injunction In ITW GSE APS Vs. Dabico Airport Solutions

- Manisha Singh - Lex Orbis,

India – Madras High Court Denies Patent To IIT Madras Based On Lack Of Data To Establish Economic Significance

- Manisha Singh - Lex Orbis,

India – Echoes Of Justice: The Delhi High Court’s Take On Saregama And Emami’s Copyright Clash

- Manisha Singh - Lex Orbis,

‘Dose’, ‘Dosage’, ‘Dosage Form’ And ‘Dosage Regimens’: Patentability In India

- DPS Parmar - Lex Orbis,

The Power Of Data-Driven Strategies

India – Cyril Amarchand Mangaldas Advises Kedaara Capital And Partners Group On Sale Of Controlling Stake In Aavas Financiers Limited To CVC.

India – Cyril Amarchand Mangaldas Advised SVf Frog (Cayman) Ltd, As Selling Shareholder In The Initial Public Offer Of Brainbees Solutions Limited.

India – Blacklisting – A Proportionate Sanction Or A Corporate Exile?

India – IFSC Funds Regime 2.0: Sweeping Changes Proposed By IFSC Authority.

- Vivaik Sharma - Cyril Amarchand Mangaldas, Cyril Amarchand Mangaldas

India – Buy-back Of Shares: Will Recent Changes In The Tax Laws End The Party?

- Bharat Vasani - Cyril Amarchand Mangaldas,

India – Regulatory Framework Governing Employee Benefits By Equity Listed Companies.